Top
Main

All outcomes

Feedback
Home
Show Outline
Top   Main   All Outcomes
Home   COVID-19 treatment studies for Nitric Oxide  COVID-19 treatment studies for Nitric Oxide  C19 studies: Nitric Oxide  Nitric Oxide   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Melatonin (meta)
Aspirin (meta) Metformin (meta)
Bamlaniv../e.. (meta) Molnupiravir (meta)
Bebtelovimab (meta) N-acetylcys.. (meta)
Bromhexine (meta) Nigella Sativa (meta)
Budesonide (meta) Nitazoxanide (meta)
Cannabidiol (meta) Nitric Oxide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)
Lactoferrin (meta)

Other Treatments Global Adoption
Loading...
Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Vitamin A
Vitamin C
Vitamin D
Zinc
Supplementary Data — Nitric Oxide for COVID-19: real-time meta analysis of 6 studies
Covid Analysis, August 12, 2022, DRAFT
https://c19early.com/nometa.html
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Winchester (DB RCT) 42% 0.58 [0.36-0.94] no improv. 8/15 23/25 Improvement, RR [CI] Treatment Control Winchester (DB RCT) 51% 0.49 [0.32-0.75] viral load 40 (n) 40 (n) Tandon (DB RCT) 42% 0.58 [0.33-1.01] no improv. 14/64 26/69 Tandon (DB RCT) 67% 0.33 [0.11-0.97] no improv. 4/64 13/69 Tandon (DB RCT) 68% 0.32 [0.09-1.12] no improv. 3/64 10/69 Tandon (DB RCT) 22% 0.78 [0.32-1.89] no improv. 8/105 10/102 Tandon (DB RCT) 18% 0.82 [0.39-1.75] no improv. 11/105 13/102 Tandon (DB RCT) 9% 0.91 [0.60-1.38] no improv. 30/105 32/102 Tandon (DB RCT) 20% 0.80 [0.75-0.86] viral load 64 (n) 69 (n) Tandon (DB RCT) 14% 0.86 [0.83-0.90] viral load 105 (n) 102 (n) Tandon (DB RCT) 26% 0.74 [0.52-1.05] viral time 64 (n) 69 (n) Tandon (DB RCT) 6% 0.94 [0.70-1.25] viral time 105 (n) 102 (n) Chandel -54% 1.54 [0.72-2.78] death 12/66 36/206 Chandel -27% 1.27 [0.82-1.73] ventilation 29/66 79/206 Moni (RCT) 90% 0.10 [0.01-1.67] death 0/14 4/11 ICU patients Moni (RCT) 90% 0.10 [0.01-1.67] ventilation 0/14 4/11 ICU patients Moni (RCT) 42% 0.58 [0.05-1.00] no improv. 3/14 7/11 ICU patients Moni (RCT) 64% 0.36 [0.17-0.74] viral load 14 (n) 11 (n) ICU patients Moni (RCT) 63% 0.37 [0.18-0.75] viral load 14 (n) 11 (n) ICU patients Valsecchi 58% 0.42 [0.02-9.86] death 0/20 1/51 Valsecchi 68% 0.32 [0.08-1.26] ventilation 2/20 16/51 Valsecchi 39% 0.61 [0.27-1.39] ICU 5/20 21/51 SaNOtize 75% 0.25 [0.14-0.43] cases 13/203 108/422 nitric oxide COVID-19 outcomes c19early.com/no Aug 2022 Favors nitric oxide Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit